CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
-3.3%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$991M
AUM Growth
+$991M
(-18%)
Cap. Flow
-$155M
Cap. Flow
% of AUM
-15.62%
Top 10 Holdings %
Top 10 Hldgs %
57.93%
Holding
48
New
8
Increased
12
Reduced
4
Closed
12
Top Buys
| 1 |
GSK
GSK
|
$55.2M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
$49.4M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$44.9M |
| 4 |
Orthofix Medical
OFIX
|
$33.8M |
| 5 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$23.9M |
Top Sells
| 1 |
Elevance Health
ELV
|
$75.3M |
| 2 |
Community Health Systems
CYH
|
$63M |
| 3 |
HCA Healthcare
HCA
|
$50.7M |
| 4 |
Tenet Healthcare
THC
|
$42.2M |
| 5 |
Labcorp
LH
|
$41M |
Sector Composition
| 1 | Healthcare | 76.59% |
| 2 | Consumer Discretionary | 2.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Teva Pharmaceuticals
TEVA
$21.1B
| $94.1M | 8.84% | 1,750,000 | – | – |
|
2
Viatris
VTRS
$12.3B
| $63.7M | 5.98% | 1,400,000 +400,000 | +40% | +$18.2M |
|
3
Masimo
MASI
$7.59B
| $57.5M | 5.4% | 2,700,000 +880,000 | +48% | +$18.7M |
|
|
GHDX
4
DELISTED
Genomic Health, Inc.
GHDX
| $56.6M | 5.32% | 2,000,000 +275,000 | +16% | +$7.79M |
|
|
5
GSK
GSK
$79.9B
| $55.2M | 5.18% | +1,200,000 | New | +$55.2M |
|
|
VOLC
6
DELISTED
VOLCANO CORPORATION COM STK
VOLC
| $53.7M | 5.05% | 5,050,000 +1,900,000 | +60% | +$20.2M |
|
7
CONMED
CNMD
$1.68B
| $51M | 4.79% | 1,385,000 | – | – |
|
|
ESRX
8
DELISTED
Express Scripts Holding Company
ESRX
| $49.4M | 4.65% | +700,000 | New | +$49.4M |
|
|
KERX
9
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $48.1M | 4.52% | 3,500,000 +500,000 | +17% | +$6.88M |
|
|
10
Vertex Pharmaceuticals
VRTX
$100B
| $44.9M | 4.22% | +400,000 | New | +$44.9M |
|
|
11
Orthofix Medical
OFIX
$592M
| $37.5M | 3.52% | 1,210,164 +1,091,481 | +920% | +$33.8M |
|
|
UAM
12
DELISTED
Universal American Corp
UAM
| $33.6M | 3.16% | 4,178,259 | – | – |
|
|
ACHN
13
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $32.4M | 3.05% | 3,250,000 -2,550,000 | -44% | -$25.4M |
|
|
ARIA
14
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $32.4M | 3.04% | 6,000,000 +1,000,000 | +20% | +$5.4M |
|
15
Quest Diagnostics
DGX
$20.3B
| $30.3M | 2.85% | 500,000 -600,000 | -55% | -$36.4M |
|
|
WW
16
DELISTED
WW International
WW
| $27.4M | 2.58% | 1,000,000 +150,000 | +18% | +$4.12M |
|
|
AMAG
17
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $23.9M | 2.25% | +750,000 | New | +$23.9M |
|
|
SQNM
18
DELISTED
SEQUENOM INC NEW
SQNM
| $23.8M | 2.23% | 8,000,000 +1,700,000 | +27% | +$5.05M |
|
19
Novavax
NVAX
$1.21B
| $19.8M | 1.86% | 4,750,000 | – | – |
|
20
Bruker
BRKR
$5.16B
| $18.5M | 1.74% | 1,000,000 +500,000 | +100% | +$9.26M |
|
21
ICU Medical
ICUI
$3.15B
| $17.8M | 1.67% | 277,583 | – | – |
|
|
BRLI
22
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
| $15.3M | 1.43% | 543,724 | – | – |
|
|
WCG
23
DELISTED
Wellcare Health Plans, Inc.
WCG
| $14.2M | 1.33% | +235,174 | New | +$14.2M |
|
|
OTIC
24
DELISTED
Otonomy, Inc.
OTIC
| $13.8M | 1.29% | +573,000 | New | +$13.8M |
|
|
AMRN
25
Amarin Corp
AMRN
$311M
| $13.1M | 1.23% | 12,000,000 +1,000,000 | +9% | +$1.09M |
|